Featured · Health
Intuitive Surgical is 35% off its high as a court, J&J and Medtronic test its robot monopoly
A revived antitrust case, two newly cleared rivals and a return to the cardiac market it walked away from in 1998 all converge on the October 20 report. Hospitals pay the instrument-and-service lock-in; ISRG shareholders are carrying the de-rate.
· 3 min read
